Back to top
more

Medtronic (MDT)

(Real Time Quote from BATS)

$80.47 USD

80.47
221,784

+0.50 (0.63%)

Updated Jul 25, 2024 10:06 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Medtronic (MDT) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Medtronic (MDT) Stock Sinks As Market Gains: Here's Why

Medtronic (MDT) closed at $79.30 in the latest trading session, marking a -0.23% move from the prior day.

Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

Medtronic (MDT) closed the most recent trading day at $78.10, moving +1.32% from the previous trading session.

Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing

The latest trading day saw Medtronic (MDT) settling at $77.06, representing a +0.23% change from its previous close.

Mark Vickery headshot

Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AbbVie Inc. (ABBV) and AstraZeneca PLC (AZN), as well as two micro-cap stocks, Air T, Inc. (AIRT) and United-Guardian, Inc. (UG).

Urmimala Biswas headshot

Medtronic Loses 5% in a Month: What's Next for MDT Investors?

Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.

Indrajit Bandyopadhyay headshot

Intuitive Surgical (ISRG) Rises 10% in a Month: What's Next?

Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Medtronic (MDT) Shares Positive Data for MiniMed 780G System

Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.

Moumi Mondal headshot

3 Generative AI-Based MedTech Stocks to Keep an Eye On

With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.

Medtronic (MDT) Cardiovascular Business Expands Amid Macro Woes

For Hugo surgical robot, Medtronic (MDT) is scaling manufacturing production, expanding regulatory approvals and ramping up installations to see continued progress internationally.

Sheraz Mian headshot

Top Stock Reports for NVIDIA, Tesla & Linde

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Tesla, Inc. (TSLA) and Linde plc (LIN), as well as two micro-cap stocks Servotronics, Inc. (SVT) and The Cato Corporation (CATO).

Santanu Roy  headshot

Watch These 5 Stocks That Recently Hiked Dividends

Investors may keep a tab on stocks like HLNE, RL, SPTN, EQH and MDT, which have lately hiked their dividend payments.

Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial

Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.

Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.

Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Medtronic (MDT) Q4 Earnings and Revenues Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 0.69% and 1.80%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade

Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.

Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome

Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.

Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know

Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Medtronic (MDT) Advances While Market Declines: Some Information for Investors

In the closing of the recent trading day, Medtronic (MDT) stood at $83.52, denoting a +0.82% change from the preceding trading day.

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen (XGN) delivered earnings and revenue surprises of 52.50% and 9.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Moumi Mondal headshot

Here's How Medtronic (MDT) Is Placed Ahead of Q4 Earnings

Medtronic's (MDT) rapid cadence of new product approvals is a strong foundation for future growth. However, the company also navigates some macroeconomic challenges.

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?